Cargando…
Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests
Direct-to-consumer genetic tests (DTC-GT) have become a bridge between marketing and traditional healthcare services. After earning FDA endorsement for such facilities, several fast-developing companies started to compete in the related area. Pharmacogenomic (PGx) tests have been introduced as poten...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999840/ https://www.ncbi.nlm.nih.gov/pubmed/33802585 http://dx.doi.org/10.3390/genes12030361 |